Several studies have shown that the LKB1-AMPK-ACC signaling pathway plays a non-negligible role in the development of tumors, including breast, prostate, ovarian, and hepatocellular carcinomas (Yang et al., 2018; Galdieri et al., 2016; Jeong et al., 2017). This evidence concerns the gene STK11 and hepatocellular carcinoma.